Trial intelligence / Profile preview

Oral Glutathione for Skin Whitening

NCT04105504Phase 1Completed

Start
Apr 2018
Primary completion
Jun 2018
Modality
Peptides, Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial comparing Glutathione Group with Placebo Group (2 arms). Primary endpoints: Change from Baseline Spot UV at 12 weeks, Change from Baseline Spot Polarization at 12 weeks and 1 more. Started Apr 2018; status: completed.

02

Drugs

glutathione

Beyond the preview

Go deeper on NCT04105504.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04105504.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call